Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
5,220,166
-
Share change
-
-484,021
-
Total reported value
-
$900,985,426
-
Put/Call ratio
-
59%
-
Price per share
-
$172.62
-
Number of holders
-
227
-
Value change
-
-$80,585,265
-
Number of buys
-
79
-
Number of sells
-
122
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q2 2021
As of 30 Jun 2021,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
227 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,220,166 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, Raymond James Financial Services Advisors, Inc., ROYAL BANK OF CANADA, RAYMOND JAMES & ASSOCIATES, OSAIC HOLDINGS, INC., and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
227
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.